Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 055541/0015 | |
| Pages: | 7 |
| | Recorded: | 03/09/2021 | | |
| Attorney Dkt #: | ULG-001C1/122626-5001 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17187168
|
Filing Dt:
|
02/26/2021
|
|
Publication #:
|
|
Pub Dt:
|
08/19/2021
| | | | |
|
Title:
|
USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS IMPERFECTA
|
|
|
Assignee
|
|
|
|
|
| POSTFACH |
| BASEL, SWITZERLAND 4002 |
|
|
Correspondence name and address
|
| |
MARK L. HAYMAN
|
| |
MORGAN, LEWIS & BOCKIUS LLP
|
| |
1111 PENNSYLVANIA AVE, N.W.
|
| |
WASHINGTON, DC 20004
|
Search Results as of:
06/07/2024 03:34 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
